BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 257 filers reported holding BALCHEM CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,273 | -61.5% | 4,533 | -58.2% | 0.00% | -66.7% |
| Q2 2023 | $1,460,666 | +2.0% | 10,835 | -4.3% | 0.01% | 0.0% |
| Q1 2023 | $1,431,880 | +54.2% | 11,321 | +48.9% | 0.01% | +20.0% |
| Q4 2022 | $928,402 | -36.4% | 7,603 | -36.7% | 0.01% | -37.5% |
| Q3 2022 | $1,460,000 | -31.8% | 12,012 | -27.2% | 0.01% | -27.3% |
| Q2 2022 | $2,140,000 | -3.4% | 16,496 | +1.8% | 0.01% | 0.0% |
| Q1 2022 | $2,216,000 | -16.1% | 16,208 | +3.5% | 0.01% | 0.0% |
| Q4 2021 | $2,640,000 | +49.2% | 15,656 | +28.3% | 0.01% | +37.5% |
| Q3 2021 | $1,770,000 | +48.1% | 12,204 | +28.1% | 0.01% | +33.3% |
| Q1 2021 | $1,195,000 | -21.3% | 9,526 | -27.7% | 0.01% | -25.0% |
| Q4 2020 | $1,518,000 | -34.8% | 13,179 | -44.8% | 0.01% | -42.9% |
| Q3 2020 | $2,330,000 | +1.4% | 23,865 | -1.4% | 0.01% | 0.0% |
| Q2 2020 | $2,297,000 | -38.3% | 24,211 | -35.8% | 0.01% | -48.1% |
| Q1 2020 | $3,722,000 | +93.4% | 37,698 | +99.0% | 0.03% | +125.0% |
| Q4 2019 | $1,925,000 | – | 18,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 425,686 | $49,048,000 | 36.25% |
| Conestoga Capital Advisors, LLC | 939,134 | $108,207,000 | 1.72% |
| Tributary Capital Management, LLC | 197,207 | $22,722,000 | 1.63% |
| Ellsworth Advisors, LLC | 16,335 | $1,882,000 | 1.36% |
| GENEVA CAPITAL MANAGEMENT LLC | 693,677 | $79,926,000 | 1.35% |
| Brown Capital Management | 1,391,418 | $160,319,000 | 1.11% |
| BARD ASSOCIATES INC | 107,550 | $12,390,000 | 0.98% |
| Advantage Alpha Capital Partners LP | 38,370 | $4,421,000 | 0.97% |
| MOODY ALDRICH PARTNERS LLC | 50,270 | $5,792,000 | 0.94% |
| Cutter & CO Brokerage, Inc. | 29,369 | $3,384,000 | 0.89% |